Ichilov becomes the first in the world to begin a clinical trial of a new lung cancer drug
Published
Ichilov Hospital in Tel Aviv announced on Thursday that it has been selected to be the first medical center in the world to begin a clinical trial of a new drug for lung cancer. This is an important announcement for patients and doctors in Israel, because the trial will start at a hospital in the country before other centers around the world.
A clinical trial is a study that examines whether a new drug is safe and effective for patients. Before a drug enters regular use, it must go through stages of testing like this. The new treatment is intended for patients with lung cancer, but the full details about the type of disease and the conditions for participating in the trial do not appear in the published report.
Lung cancer is one of the most common and most dangerous types of cancer in the world. Therefore, any study that attempts to find new treatments receives considerable attention from the medical community and the public. People who want to know whether they can take part in the trial should contact their treating physician or the hospital itself.
The hospital issued the announcement about the start of the trial, and the picture will become clearer when further details are published. In the meantime, the trial marks an important step forward in efforts to find new treatments for lung cancer.
Sources: היום
More Israel news
- Israel and France Explore New Approaches to Mental Health Care
- Sudden Facial Paralysis and Diabetes: What a New Israeli Study Shows
- A U.S. Medical Delegation Visited Laniado Hospital in Netanya
- A Special Crossing Over Route 6: A Bridge for Wildlife
- Revolut Receives Conditional License to Establish a Bank in Israel
- Ministry of Health Cancels Water Boiling Order in Kfar Chabad
- Eisenkot and opposition leaders agree on candidates for key Knesset positions
- Exiled Iranian Prince: Iran Is Likely to Use Nuclear Weapons Against Israel